Reneuron Share Discussion Threads

[milliecusto] 08/5/2019 19:57

I won't answer ridiculous questions with what they do to distract your failings for not understanding a resistance point in a chart and not understanding when a Rns is good or bad, what I will indulge in is that I made a significant profit in toop, sold today, bought back into ecr and already have a attractive gain and having bought Tullow today now in a profit, albeit a small one so far, all this from selling rene last week due to concerns regarding the share price volume.So whilst you have been trying to score points off me on this bb, I have been trading and made some very nice gains, if you had paid attention to me, you might have made more money or saved some.I couldn't care less what companies do, I read the news, look at the chart and then decide to buy, I sell when the share price starts to go against me, simples.I wonder from the two of us who is the happier person.All this from a telecoms procurement guy who missed out on 60% plus no brainier gain in a week on toop

[stevee1234] 08/5/2019 17:17

Link to Michael Hunt interview

hxxps://youtu.be/vTc4grkmn6E

[daffodil4] 08/5/2019 16:36

Micael Hunt Interview out on Proactive Investor...

[eggy6198] 08/5/2019 15:23

Its a nasty name troll as i am sure he doesnt live under a bridge.

[martinfrench] 08/5/2019 15:03

funny answer to the question......

[milliecusto] 08/5/2019 14:59

Recently had been invested,as noted on here, concerning recent volume not enough to break through 52 wk high, watch with interest however, here to make money not fall for a share

[eggy6198] 08/5/2019 13:24

Milliescuto out of interest what to Rene do?

[jensonbensonjohnson] 08/5/2019 12:57

Makes sense to treat those with worse eyesight first just in case of any unforeseen negative effects. Proactive article is wrong.

[sja123] 08/5/2019 12:21

Good write up but an error in the text I think....they say "The vision of this latest trio is more impaired than the first"....

...whereas I believe the latest trio have better visual acuity to start with than the first cohort.....

[milliecusto] 08/5/2019 12:02

If it's such a good Rns, why the drop, market is rarely wrong, cash burn says it all...

[milliecusto] 08/5/2019 12:01

Yeah Toop nearly doubled now, Rene went back 10%, I wonder who the more savvy investors are

[daffodil4] 08/5/2019 11:53

Proactive Investor's that is...

[daffodil4] 08/5/2019 11:52

Check Out today's Proactive review of the RNS!
Says it all.....


GLA!

[supernumerary] 08/5/2019 10:25

I assume the expected delay to the stroke disability trial is because they're planning to include a Chinese cohort in conjunction with Fosun. This will inevitably take some time to set up, but will open up the Chinese market when approval is obtained. It's good to see them moving ahead with this.

Esmerelda - they've already completed dosing of the second hRPC cohort. News in July is nailed on, if not before.

As regards money, this is probably the first time in their entire existence they don't have to worry about it!

[daffodil4] 08/5/2019 10:20

As a company grows the operating costs go up...
some on here have no understanding of basic business...

[jensonbensonjohnson] 08/5/2019 09:53

Only negative thing in RNS is delay to stroke trial results which isn't particularly significant; we don't want the trial to be hurried. Everything else is positive with strong hints of commercial deals to come. Looks like a wink-wink nudge-nudge report to me. Major shareholders not going anywhere, board recent buying, company incentive scheme includes incentives to double share price and do more deals and more trials. Follow the big money; hold and win. Simples.

I would like to see them resurrect the critical limb ischemia work through a new partner. I was disappointed when they had to drop that to focus on stroke. It's much less invasive than brain surgery and the market, with levels of diabetes in the West, is enormous.

[eggy6198] 08/5/2019 09:48

Haha uou do sound like a muppett. Risk incraesed haha. Simple maths 26+6+ nes deals minus 11.... ooo risky.

Back to toople with you guys

[martinfrench] 08/5/2019 09:43

i dont think any of us who hold rene are bothered if you invest or not

[milliecusto] 08/5/2019 09:42

Burn rate of cash far to high, need to see more good news on results before investing, seems risk has increased significantly

[martinfrench] 08/5/2019 09:27

Esmerelda is right, company obligation to state no more cash needed for next 12 moths, until next set of results.

nothing at all to worry about, bought few more, back to £3 in no time.

[eggy6198] 08/5/2019 09:26

Okay so burn rate has been at 11m they have 26m in bank and 6m coming

Lots of interest from commerical partners and 3 years money in bank which gives strong negotation position

Nezt results are 60 days after completed treatment so qorst case july which i had guessed.

Other results q2.

Delay on stroke programme but thats no interest to my investment.

In summary commerical deals anytime new info only guessed at before. 3 years money and 2nd resulta 3rd and 4th results from july onwards

[daffodil4] 08/5/2019 09:09

RENE will be self funding going forward...

The RNS clearly details the potential deals
in the short term.....Every reason to believe
there will be no further fund raising here....

All sells bought up today...

[manc10] 08/5/2019 09:02

it should be ok with no placing for 12 months , in other words placing ahoy it must be burning cash for fun

[esmerelda] 08/5/2019 08:49

I would expect to hear news from the next patient treatment programme when the results are announced in July. The wording in the RNS is a little confusing but my take on it is that there will be four cohorts, each of three people who have a better starting vision. The first cohort has already been treated and the others are being recruited. One of the slides in the recent presentation (link in thread if you go back a week or two) shows that vision improvement in the treated patients took place on a continuous basis over the first 30 days or so. I expect the company will be able (and will want) to report progress on how the first cohort in this phase is progressing by the time of the results announcement.

[tewkesbury] 08/5/2019 08:45

Looks like TT was well right about Toople. Up 27% yesterday and 18% this morning, and 100x bagger written all over it.